Thiophene

Thiophene

SCHEMBL497680

Cl.[Cu].c1ccsc1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Thiophene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thiophene SCHEMBL1222753 0.95
Thiophene SCHEMBL3800049 0.95
Thiophene SCHEMBL4349054 0.95
Thiophene SCHEMBL27990041 0.95
Thiophene SCHEMBL15534104 0.90
Thiophene SCHEMBL28773847 0.90
Hydrochloric Acid SCHEMBL28746197 0.90 TP53 (0.30)
Thiophene SCHEMBL4337734 0.90
Hydrochloric Acid SCHEMBL753095 0.90 TP53 (0.30)
Thiophene SCHEMBL29228162 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7067681-B2 Methods of preparing substituted tetracyclines with transition metal-based chemistries TRUSTEES OF TUFTS COLLEGE (US) 2006-06-27 US claimed
US-20040033996-A1 Methods of preparing substituted tetracyclines with transition metal-based chemistries PARATEK PHARMACEUTICALS, INC. 2004-02-19 US claimed
US-20130029943-A1 Methods of Preparing Substituted Tetracyclines with Transition Metal-Based Chemistries TRUSTEES OF TUFTS COLLEGE (US) 2013-01-31 US disclosed
US-8106225-B2 Catalytically reacting a 7(9)- arene tetracycline diazonium salt or an iodotetracycline and a reactive substituent precursor, e.g., (substituted) alkenes, vinyl monomers, aromatics, carbon monoxide; carboxylation, esterification, amidation carbonylation, cyanation; anhydriding; imidation; bactericides TRUSTEES OF TUFTS COLLEGE (US) 2012-01-31 US disclosed
EP-2204361-B1 13-substituted methacycline compounds TUFTS COLLEGE (US) 2011-09-28 EP disclosed
EP-1666454-B1 Methods of preparing substituted tetracyclines with transition metal-based chemistries TUFTS COLLEGE (US) 2011-09-07 EP disclosed
EP-2327686-A2 Methods of preparing substituted tetracyclines with transition metal-based chemistries TRUSTEES OF TUFTS COLLEGE (US) 2011-06-01 EP disclosed
EP-2327687-A2 Methods of preparing substituted tetracyclines with transition metal-based chemistries TRUSTEES OF TUFTS COLLEGE (US) 2011-06-01 EP disclosed
EP-2204361-A1 13-substituted methacycline compounds TRUSTEES OF TUFTS COLLEGE (US) 2010-07-07 EP disclosed
EP-1661883-B1 13-substituted methacycline compounds TUFTS COLLEGE (US) 2010-04-28 EP disclosed
US-7696187-B2 Methods of preparing substituted tetracyclines with transition metal-based chemistries TRUSTEES OF TUFTS COLLEGE (US) 2010-04-13 US disclosed
WO-2003079983-A2 METHODS OF PREPARING SUBSTITUTED TETRACYCLINES WITH TRANSITION METAL-BASED CHEMISTRIES TRUSTEES OF TUFTS COLLEGE (US) 2003-10-02 WO disclosed
US-6617318-B1 7-substitted tetracyclines are effective against tetracycline-resistant E. coli, S. aureus and E. faecalis strains TRUSTEES OF TUFTS COLLEGE 2003-09-09 US disclosed
US-20030166952-A1 13-substituted methacycline compounds PARATEK PHARMACEUTICALS, INC. 2003-09-04 US disclosed
EP-1301465-A2 13-SUBSTITUTED METHACYCLINE COMPOUNDS TRUSTEES OF TUFTS COLLEGE (US) 2003-04-16 EP disclosed
US-6500812-B2 GASTROINTESTINAL DISORDERS; ANTIINFLAMMATORY AGENTS PARATEK PHARMACEUTICALS, INC. 2002-12-31 US disclosed
US-20020147182-A1 13-substituted methacycline compounds PARATEK PHARMACEUTICALS, INC. 2002-10-10 US disclosed
EP-1240133-A1 METHODS OF PREPARING SUBSTITUTED TETRACYCLINES WITH TRANSITION METAL-BASED CHEMISTRIES TRUSTEES OF TUFTS COLLEGE (US) 2002-09-18 EP disclosed
WO-2002004405-A2 13-SUBSTITUTED METHACYCLINE COMPOUNDS TRUSTEES OF TUFTS COLLEGE (US) 2002-01-17 WO disclosed
WO-2001019784-A1 METHODS OF PREPARING SUBSTITUTED TETRACYCLINES WITH TRANSITION METAL-BASED CHEMISTRIES TRUSTEES OF TUFTS COLLEGE (US) 2001-03-22 WO disclosed